149 related articles for article (PubMed ID: 37549741)
1. Development of a physiologically based toxicokinetic model for lead in pregnant women: The role of bone tissue in the maternal and fetal internal exposure.
Ali Daoud Y; Tebby C; Beaudouin R; Brochot C
Toxicol Appl Pharmacol; 2023 Oct; 476():116651. PubMed ID: 37549741
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Framework to Predict Maternal-Placental-Fetal Pharmacokinetics of Nifedipine Employing Physiologically Based Pharmacokinetic Modeling Approach.
Werdan Romão MA; Pinto L; Cavalli RC; Duarte G; de Moraes NV; Abduljalil K; Moreira FL
J Clin Pharmacol; 2024 May; 64(5):568-577. PubMed ID: 38305718
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.
Zhang Z; Imperial MZ; Patilea-Vrana GI; Wedagedera J; Gaohua L; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):920-938. PubMed ID: 28588050
[TBL] [Abstract][Full Text] [Related]
4. PBPK modeling to support risk assessment of pyrethroid exposure in French pregnant women.
Thépaut E; Bisson M; Brochot C; Personne S; Appenzeller BMR; Zaros C; Chardon K; Zeman F
Environ Res; 2024 Jun; 251(Pt 1):118606. PubMed ID: 38460660
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy.
Chen Y; Ke M; Fang W; Jiang Y; Lin R; Wu W; Huang P; Lin C
Eur J Pharm Sci; 2024 Mar; 194():106707. PubMed ID: 38244810
[TBL] [Abstract][Full Text] [Related]
6. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
Balhara A; Kumar AR; Unadkat JD
J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Yan Y; Wang Q; Wu W; Yi H; Xie F
Pharm Res; 2024 May; 41(5):899-910. PubMed ID: 38684563
[TBL] [Abstract][Full Text] [Related]
9. The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data.
Sharma RP; Schuhmacher M; Kumar V
Sci Total Environ; 2018 May; 624():55-68. PubMed ID: 29247905
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Placental Transfer and Tissue Distribution of
Personne S; Brochot C; Marcelo P; Corona A; Desmots S; Robidel F; Lecomte A; Bach V; Zeman F
Front Pediatr; 2021; 9():730383. PubMed ID: 34631627
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
13. Assessing lead exposure in U.S. pregnant women using biological and residential measurements.
Stanek LW; Grokhowsky N; George BJ; Thomas KW
Sci Total Environ; 2023 Dec; 905():167135. PubMed ID: 37739076
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Coupling of a Novel
Mian P; Nolan B; van den Anker JN; van Calsteren K; Allegaert K; Lakhi N; Dallmann A
Front Pediatr; 2021; 9():733520. PubMed ID: 34631628
[TBL] [Abstract][Full Text] [Related]
15. Maternal blood concentrations of toxic metal(loid)s and trace elements from preconception to pregnancy and transplacental passage to fetuses.
Zhang T; Wang X; Luo ZC; Liu J; Chen Y; Fan P; Ma R; Ma J; Luo K; Yan CH; Zhang J; Ouyang F;
Ecotoxicol Environ Saf; 2023 Oct; 264():115394. PubMed ID: 37625333
[TBL] [Abstract][Full Text] [Related]
16. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.
Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A
Clin Pharmacokinet; 2020 Jul; 59(7):911-925. PubMed ID: 32052378
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?
Liu XI; Green DJ; van den Anker JN; Rakhmanina NY; Ahmadzia HK; Momper JD; Park K; Burckart GJ; Dallmann A
Front Pediatr; 2021; 9():723006. PubMed ID: 34733804
[No Abstract] [Full Text] [Related]
18. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
[TBL] [Abstract][Full Text] [Related]
19. Lead exposure and serum metabolite profiles in pregnant women in Mexico City.
Niedzwiecki MM; Eggers S; Joshi A; Dolios G; Cantoral A; Lamadrid-Figueroa H; Amarasiriwardena C; Téllez-Rojo MM; Wright RO; Petrick L
Environ Health; 2021 Dec; 20(1):125. PubMed ID: 34893088
[TBL] [Abstract][Full Text] [Related]
20. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
Zhang Z; Unadkat JD
Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
